Global Cancer Diagnostics Market is expected to grow at a CAGR of 9.5% during the forecast period 2020-2025. The market is segmented into Types, Applications (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancers, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, and Other Cancers), End User, and Region. A research report by Foster Market Research provides deep market insight that will help your business to grow with an improved go-to-market business strategy.
Important Thing Need To Know About
Upcoming Cancer Diagnostics Market In 2025
The global cancer diagnostics market was valued at US$ xx million in the year 2019.
This market is estimated to be valued at US$ xx million in the year 2020, and it is expected
to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the
forecast period (2020-2025).
Cancer diagnostics refers to the techniques deployed for diagnosing cancer. A range of
imaging techniques is used for diagnosing cancer, including bone scan, computerized
tomography (CT) scan, ultrasound and X-ray, positron emission tomography (PET) scan,
and magnetic resonance imaging (MRI), among others. Technological advancements,
initiatives adopted by government worldwide and global health organizations to develop
awareness about cancer, rising prevalence of cancer, rise in the number of private
diagnostics centers, public-private partnerships to boost infrastructure of diagnostic
imaging centers, and FDA (Food and Drug Administration) support for biomarker
development and introduction of novel flow cytometry reagents for drug discovery and
diagnostics have increased the demand for the cancer diagnostics market.
● Latest Updates
● Analyst Views
● Future Outlook of the Market
Get Free PDF Brochure of this Report @
Key players in global cancer diagnostics market include Exact Sciences Corporation, Arquer
Diagnostics Ltd., BioMark Diagnostics Inc., Biotheranostics, Cancer Diagnostics, Inc.,
Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Becton, Dickinson
and Company (BD), GE Healthcare, QIAGEN N.V., Abbott Laboratories, Inc., Roche
Diagnostics, Siemens Healthcare, and Koninklijke Philips N.V., Inc., among others.
The market is competitive with several small and medium enterprises (SMEs). The major
strategy adopted by the SME is acquisition to gain the market share.